Aviance Capital Partners, LLC Biogen Inc. Transaction History

Aviance Capital Partners, LLC

  • $733 Million
  • Q3 2024

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024
BUY
$190.52 - $236.72 $3,619 - $4,497
19 Added 1.96%
989 $229,000
Q1 2024

Apr 17, 2024
SELL
$212.02 - $267.71 $12,721 - $16,062
-60 Reduced 5.83%
970 $209,000
Q4 2023

Feb 06, 2024
SELL
$222.59 - $267.94 $1,112 - $1,339
-5 Reduced 0.48%
1,030 $266,000
Q2 2023

Aug 04, 2023
SELL
$275.25 - $318.06 $27,525 - $31,806
-100 Reduced 8.81%
1,035 $294,000
Q4 2022

Feb 06, 2023
SELL
$252.44 - $306.72 $12,622 - $15,336
-50 Reduced 4.22%
1,135 $314,000
Q3 2022

Nov 09, 2022
SELL
$194.69 - $268.46 $38,353 - $52,886
-197 Reduced 14.25%
1,185 $316,000
Q2 2022

Aug 08, 2022
SELL
$187.54 - $223.02 $110,648 - $131,581
-590 Reduced 29.92%
1,382 $282,000
Q1 2022

May 06, 2022
SELL
$193.77 - $244.14 $15,114 - $19,042
-78 Reduced 3.8%
1,972 $415,000
Q4 2021

Feb 07, 2022
SELL
$223.92 - $287.77 $1.98 Million - $2.55 Million
-8,849 Reduced 81.19%
2,050 $492,000
Q3 2021

Nov 12, 2021
BUY
$282.99 - $369.05 $398,732 - $519,991
1,409 Added 14.85%
10,899 $3.08 Million
Q2 2021

Aug 06, 2021
SELL
$259.0 - $414.71 $743,330 - $1.19 Million
-2,870 Reduced 23.22%
9,490 $3.29 Million
Q1 2021

Apr 29, 2021
BUY
$242.95 - $284.63 $11,904 - $13,946
49 Added 0.4%
12,360 $3.46 Million
Q4 2020

Feb 12, 2021
SELL
$236.26 - $355.63 $168,925 - $254,275
-715 Reduced 5.49%
12,311 $3.01 Million
Q3 2020

Nov 03, 2020
BUY
$264.77 - $305.71 $147,741 - $170,586
558 Added 4.48%
13,026 $3.7 Million
Q2 2020

Jul 24, 2020
BUY
$258.66 - $342.55 $102,429 - $135,649
396 Added 3.28%
12,468 $3.34 Million
Q1 2020

May 05, 2020
BUY
$268.85 - $341.04 $240,083 - $304,548
893 Added 7.99%
12,072 $3.82 Million
Q4 2019

Feb 07, 2020
SELL
$220.06 - $304.07 $880 - $1,216
-4 Reduced 0.04%
11,179 $3.32 Million
Q3 2019

Nov 07, 2019
BUY
$217.44 - $243.88 $1.14 Million - $1.28 Million
5,229 Added 87.82%
11,183 $2.6 Million
Q2 2019

Aug 12, 2019
SELL
$219.29 - $241.72 $99,119 - $109,257
-452 Reduced 7.06%
5,954 $1.39 Million
Q1 2019

May 01, 2019
BUY
$216.71 - $338.96 $120,490 - $188,461
556 Added 9.5%
6,406 $1.51 Million
Q4 2018

Feb 11, 2019
SELL
$278.5 - $352.75 $314,148 - $397,902
-1,128 Reduced 16.17%
5,850 $1.76 Million
Q3 2018

Nov 09, 2018
BUY
$293.51 - $383.83 $29,351 - $38,383
100 Added 1.45%
6,978 $2.47 Million
Q2 2018

Aug 10, 2018
BUY
$257.52 - $306.91 $782,860 - $933,006
3,040 Added 79.21%
6,878 $2 Million
Q1 2018

May 03, 2018
BUY
$260.13 - $367.91 $59,569 - $84,251
229 Added 6.35%
3,838 $1.05 Million
Q4 2017

Feb 13, 2018
SELL
$307.64 - $344.58 $43,684 - $48,930
-142 Reduced 3.79%
3,609 $1.15 Million
Q3 2017

Nov 09, 2017
BUY
$281.15 - $329.69 $1.05 Million - $1.24 Million
3,751
3,751 $1.18 Million

Others Institutions Holding BIIB

# of Institutions
1,037
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Aviance Capital Partners, LLC Portfolio

Follow Aviance Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviance Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviance Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email